Reply to letter to the editor regarding “Efficacy and safety of finerenone in patients with chronic kidney disease: a systematic review with meta-analysis and trial sequential analysis”
Zhangning Fu(Chinese PLA General Hospital), Quan Hong(Chinese PLA General Hospital), Chengcheng Song(Northeast Normal University), Xiaodong Geng(Chinese PLA General Hospital), Kun Chi(Chinese PLA General Hospital), Chao Liu(Harbin Medical University), Di Wu(Shenzhen Second People's Hospital)
Cited by 1
Related Papers
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β–Induced Angiogenesis
|Journal of the American Society of Nephrology|2019|149
Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression
|Science Advances|2023|130
IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis
|Cell Death and Disease|2022|111